Hypoxia-Inducible Factor Drives Vascularization of Modularly Assembled Engineered Tissue

Tissue Eng Part A. 2019 Aug;25(15-16):1127-1136. doi: 10.1089/ten.TEA.2018.0294. Epub 2019 Jun 14.

Abstract

Using two inhibitory methods, we demonstrated that hypoxia-inducible factor (HIF) plays an important role in vascularizing and oxygenating modularly-assembled engineered tissues. Each inhibitory technique elucidated a different mechanism by which this occurred. Whereas systemic inhibition negatively impacted early recruitment of host-derived cells, genetic inhibition in grafted endothelial cells was detrimental to their survival. Taken together, our study suggests that methods of HIF-mediated mechanisms could be harnessed to tune the extent and rate of vascularization in engineered tissue constructs.

Keywords: endothelial progenitor cells; flow cytometry; hypoxia; modular tissue engineering; siRNA; vascularization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / drug effects
  • Digoxin / pharmacology
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Male
  • Mice, SCID
  • Neovascularization, Physiologic* / drug effects
  • Prostheses and Implants
  • RNA, Small Interfering / metabolism
  • Tissue Engineering*
  • Tissue Scaffolds / chemistry

Substances

  • Hypoxia-Inducible Factor 1, alpha Subunit
  • RNA, Small Interfering
  • Digoxin